Reaction
Pancreas Transplant Rejection reporting signals
As of the last recalculation, Pancreas Transplant Rejection appears in 201 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is TACROLIMUS (PRR 377.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Tacrolimus | 149 | 377.9 | 378.3 |
| Anti-Thymocyte Globulin (Rabbit) | 23 | 333.3 | 334.2 |
| Basiliximab | 26 | 262.8 | 263.4 |
| Tacrolimus Extended-Release Capsules | 111 | 204.4 | 204.5 |
| Tacrolimus Ointment 0.1% | 110 | 200.8 | 201.0 |
| Mycophenilic Acid | 25 | 142.5 | 142.7 |
| Mycophenolate Mofetil | 96 | 139.2 | 139.3 |
| Mycophenolate Mofetil Hydrochloride | 96 | 139.0 | 139.1 |
| Valganciclovir Hydrochloride Powder, | 15 | 137.5 | 137.7 |
| Mycophenolic Acid | 34 | 132.2 | 132.3 |
| Valganciclovir | 20 | 121.9 | 122.0 |
| Valganciclovir Hydrochloride | 20 | 121.9 | 122.0 |
| Sirolimus | 9 | 72.4 | 72.4 |
| Amikacin | 9 | 57.1 | 57.2 |